Propagation of GABA-induced hyperpolarization at the axon regulates AP generation. by Yang Xia (104600)

“…Right, group data showing a decrease in the mean frequency of APs after GABA iontophoresis at the axon trunk. **, P<0.01, paired t-test. …”

The effect of (+)-pentazocine and H₂O₂ on ONHAs viability. by Jing Zhao (21160)

“…At the highest concentration of PTZ (50μM), there was a trend toward decrease in viability that was not significant. …”

Table_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Table_3_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

Image_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B by Teerha Piratvisuth (279131)

“…<div><h3>Background and Aims</h3><p>The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. …”

Efficacy of combined interventions including preventative NPIs (e.g., masking, distancing, lockdowns) and testing and isolation. by Emily Howerton (10988025)

“…Moves can maintain NPI intensity with a less sensitive test (thick arrows), decrease NPI intensity with the same test (medium arrows), and decrease NPI intensity with a less sensitive test (light arrows). …”

Survival.Raw Data.Zinc.xlsx by Kilmer Oliveira Soares (11497465)

“…To evaluate survivorship, we exposed bees to six concentrations of zinc (0, 50, 100, 250, 500, or 1000 mg/L) and assessed survival daily for 10 days. …”

Resiliency in first-year medical students. by Richard K. Jordan (9525274)

“…Notice that males and females had a gradual decrease in resiliency throughout the academic year. …”

The impact of six expense types on the total operational costs. by Gemechu Tadesse Leta (802683)

“…A negative value indicates an increase in operational costs, a positive indicates a decrease in operational costs.…”

<i>L. gasseri</i> secretes thermostable, bioactive molecule(s) of proteinaceous nature during the stationary phase of growth. by Blanda Di Luccia (407048)

“…<p>HCT116 cells were incubated in complete cell culture medium supplemented or not with TNFα (1 nM) for 8 hours and with A) CM fractionated with a cut-off of 3 kDa, or B) CM treated with different enzymes [Trypsin, Proteinase K, DNAse I, RNAse A], or C) CM treated at 100°C for 30 minutes, or D) CM of cultures at the indicated phases of growth. …”

The Majority of MgpB-Reactive Antibodies Bind to the Surface of Intact <i>M</i>. <i>genitalium</i> Cells. by Stefanie L. Iverson-Cabral (797308)

“…The increased reactivity with treated compared to untreated cells was significant for the conserved N-terminus (rMgpB-1; *, p = 0.024), variable region EF (rMgpB-EF; **, p < 0.001), and the putative cytoplasmic domain (rMgpB-4b; **, p = 0.0004); conversely there was a significant decrease in antibody binding in treated compared to untreated cells for the second conserved region (**, p = 0.007 and p = 0.0061 for rMgpB-2a and -2b, respectively). …”

Administration of 0 by Laure Verret (2123)

“…</p>2 μg (black line) and 1 μg (dashed line) of MCH induceda strong increase in the quantities of PS (A) and SWS (B) and a decrease in W (C) in male rats compared to NaCl (dotted line). …”

Endothelial cells expressing Bcl-2 (EC-Bcl-2) show enhanced tumor cell binding. by Arti Yadav (162897)

“…The scale bar represents 100 μm. <b>C-D;</b> tumor cell binding assays were performed in the presence or absence of neutralizing E-selectin, ICAM-1 or VCAM-1 antibodies. *, represent a significant increase and **, represent a significant decrease in adhesion molecule expression (p<0.05).…”